Compound repurposing

Filters

Small molecule compounds are being studied for repurposing in COVID-19 treament and research. Multiple small molecules that are approved to treat other disorders have shown potential effects on key proteins involved in SARS-CoV-2 host cell entry and replication. Repurposing of existing compounds is advantageous for speed - reducing timescales compared to conventional drug discovery. Researchers can save up to 50% on these small molecules for COVID-19 research, as they are up to half the price of other suppliers.

2 Items

Set Descending Direction
  1. Description:

    Sphingosine 1-phosphate (S1P/EDG) receptors analog

    Purity:

    >98%

    Pack:
    5mg
    Price:
    $526
    Qty:
  2. Description:

    Sphingosine 1-phosphate (S1P) receptor (S1P1, S1P3, S1P4, and S1P5) modulator

    Purity:

    >98%

    Pack:
    25mg
    Price:
    $276
    Qty: